Zacks Research Upgrades Oscar Health (NYSE:OSCR) to "Hold"

Key Points

• Zacks Research upgraded Oscar Health from a "strong sell" rating to a "hold" rating in a recent report.
• Oscar Health's stock has a current price target of $13.19 based on average analyst ratings, with two-thirds of analysts rating it as "hold" or "sell".
• In the latest earnings report, Oscar Health posted a 29.0% year-over-year revenue increase, but recorded an EPS of ($0.89), slightly above expectations.

Oscar Health (NYSE:OSCR - Get Free Report) was upgraded by research analysts at Zacks Research from a "strong sell" rating to a "hold" rating in a research note issued on Monday,Zacks.com reports.

OSCR has been the topic of several other reports. Robert W. Baird restated a "neutral" rating and set a $14.00 price objective (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a report on Friday, July 25th. The Goldman Sachs Group began coverage on Oscar Health in a report on Tuesday. They set a "neutral" rating and a $17.00 price objective on the stock. Barclays reduced their price objective on Oscar Health from $17.00 to $11.00 and set an "underweight" rating on the stock in a report on Wednesday, July 23rd. Finally, Wells Fargo & Company raised their price objective on Oscar Health from $10.00 to $14.00 and gave the stock an "underweight" rating in a report on Tuesday, October 7th. Six analysts have rated the stock with a Hold rating and six have assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Oscar Health currently has an average rating of "Reduce" and an average price target of $13.19.

Oscar Health Trading Up 2.0%

Shares of NYSE OSCR opened at $20.80 on Monday. The company has a debt-to-equity ratio of 0.26, a quick ratio of 0.86 and a current ratio of 0.86. The business's 50 day moving average price is $18.04 and its 200-day moving average price is $15.96. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.80. The company has a market cap of $5.38 billion, a price-to-earnings ratio of -25.68 and a beta of 1.89.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.Oscar Health's quarterly revenue was up 29.0% on a year-over-year basis. During the same period last year, the business posted $0.20 EPS. On average, sell-side analysts expect that Oscar Health will post 0.69 earnings per share for the current year.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction dated Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the completion of the sale, the insider owned 501,148 shares of the company's stock, valued at approximately $9,236,157.64. The trade was a 44.08% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 25.11% of the stock is owned by insiders.

Institutional Trading of Oscar Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its position in Oscar Health by 3.7% during the 1st quarter. Vanguard Group Inc. now owns 19,698,442 shares of the company's stock worth $258,247,000 after acquiring an additional 700,469 shares during the period. T. Rowe Price Investment Management Inc. lifted its position in Oscar Health by 4.1% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 11,826,245 shares of the company's stock worth $155,043,000 after acquiring an additional 467,301 shares during the period. Thrive Capital Management LLC lifted its position in Oscar Health by 33.4% during the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock worth $85,258,000 after acquiring an additional 1,588,395 shares during the period. BIT Capital GmbH raised its stake in shares of Oscar Health by 1.1% during the 1st quarter. BIT Capital GmbH now owns 4,521,445 shares of the company's stock valued at $59,276,000 after buying an additional 47,592 shares during the last quarter. Finally, Glynn Capital Management LLC raised its stake in shares of Oscar Health by 14.0% during the 1st quarter. Glynn Capital Management LLC now owns 3,115,217 shares of the company's stock valued at $40,840,000 after buying an additional 381,980 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.